Table: begin end state 1 20 cytoplasmic 21 45 transmembrane 46 56 non-cytoplasmic 57 81 transmembrane 82 90 cytoplasmic 91 111 transmembrane 112 117 non-cytoplasmic 118 145 transmembrane 146 157 cytoplasmic 158 179 transmembrane 180 189 non-cytoplasmic 190 209 transmembrane 210 239 cytoplasmic 240 260 transmembrane 261 269 non-cytoplasmic 270 293 transmembrane 294 304 cytoplasmic 305 327 transmembrane 328 332 non-cytoplasmic 333 351 transmembrane 352 369 cytoplasmic 370 392 transmembrane 393 399 non-cytoplasmic 400 418 transmembrane 419 425 cytoplasmic
Input: >WP_013088471.1 NCBI__GCF_000092885.1:WP_013088471.1 MNATTAASIAGSRQNSWRAVVAASIGNALEWFDLVVYGFFAVTISKLFFPAGNDTVSLLL TLGTFGVSFFMRPLGAIVIGAYSDRAGRKAALTLSIMLMMGGTLIIAILPTYQSIGLAAP LILVLARLMQGFSAGGEFGSATAFLAEHEPGRRGFYASWQMASQGLTTLLAAGFGALLTG GLSPEQMTSWGWRVPFFFGLLIGPVAFYIRTKLDETPEFLAAETTQTPLRDTFATQKLRL VIAMGVVILGTVSSYLMLFMPTYGVRQLGLAPSVAFSAIAVTGLIQMVFSPVAGHWSDLH GRTRIMLGAAVLLFVLVYPAFAFLIAHPSFGTLIVWQIVFGFLVSGYFGATPGLLSEIFP VQTRTTGMSLAYNIAVTIFGGFGPFIIAWLISVTGSKAAPSYYVMFAALLSIAALIGARR KLGFR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server